Answers are grounded in this paper and cite their sources.
The results of this trial will provide the evidence for the effect of modified MFX decoction in patients with mild bronchial asthma during acute exacerbation. It also will explore the mechanism of this formula in the treatment of bronchial asthma, which will provide another treatment option for patients with mild bronchial asthma.
No takes yet. Share an insight, caveat, or question.
Gan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: